LNSR - LENSAR, Inc. Stock Price, Fair Value and News

4.12USD-0.04 (-0.96%)Delayed

Market Summary

USD4.12-0.04

Delayed

-0.96%

LNSR Stock Price

View Fullscreen

LNSR RSI Chart

LNSR Valuation

Market Cap

47.0M

Price/Earnings (Trailing)

-3.83

Price/Sales (Trailing)

1.06

Price/Free Cashflow

-5.51

LNSR Price/Sales (Trailing)

LNSR Profitability

Operating Margin

50.45%

Return on Equity

-38.54%

Return on Assets

-18.55%

Free Cashflow Yield

-18.14%

LNSR Fundamentals

LNSR Revenue

Revenue (TTM)

44.5M

Rev. Growth (Yr)

28.31%

Rev. Growth (Qtr)

-12.53%

LNSR Earnings

Earnings (TTM)

-12.3M

Earnings Growth (Yr)

49.51%

Earnings Growth (Qtr)

45.06%

Breaking Down LNSR Revenue

Last 7 days

9.0%

Last 30 days

34.6%

Last 90 days

-11.2%

Trailing 12 Months

56.1%

How does LNSR drawdown profile look like?

LNSR Financial Health

Current Ratio

4.06

LNSR Investor Care

Shares Dilution (1Y)

2.65%

Diluted EPS (TTM)

-1.34

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	44.5M	0	0	0
2023	34.3M	38.2M	40.3M	42.2M
2022	36.8M	36.9M	36.3M	35.4M
2021	27.5M	30.4M	31.5M	34.5M
2020	29.5M	28.5M	27.4M	26.4M
2019	0	0	0	30.5M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of LENSAR, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 07, 2024	lindstrom richard l md	acquired	-	-	22,000	-
May 07, 2024	winer gary m	acquired	-	-	22,000	-
May 07, 2024	o'farrell elizabeth g.	acquired	-	-	22,000	-
May 07, 2024	weisner aimee s	acquired	-	-	22,000	-
May 07, 2024	ellis thomas b	acquired	-	-	22,000	-
May 07, 2024	link william j phd	acquired	-	-	22,000	-
May 07, 2024	hammer todd b	acquired	-	-	22,000	-
May 06, 2024	connaughton alan b.	acquired	-	-	45,000	chief operating officer
May 06, 2024	staab thomas r ii	acquired	-	-	19,000	chief financial officer
May 06, 2024	curtis nicholas t	acquired	-	-	71,400	chief executive officer

Which funds bought or sold LNSR recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	COMERICA BANK	unchanged	-	-65.00	1,943	-%
May 15, 2024	Royal Bank of Canada	reduced	-91.67	-	-	-%
May 15, 2024	CITADEL ADVISORS LLC	reduced	-17.48	-5,855	29,554	-%
May 15, 2024	BRANDES INVESTMENT PARTNERS, LP	added	46.00	379,232	1,174,860	0.01%
May 15, 2024	RBF Capital, LLC	unchanged	-	-5,659	170,101	0.01%
May 15, 2024	Park West Asset Management LLC	reduced	-2.56	-223,118	3,692,940	0.26%
May 15, 2024	TWO SIGMA SECURITIES, LLC	new	-	60,833	60,833	-%
May 15, 2024	Tower Research Capital LLC (TRC)	added	95.44	4,600	9,760	-%
May 15, 2024	Clearline Capital LP	unchanged	-	-19,549	587,695	0.03%
May 15, 2024	DCF Advisers, LLC	reduced	-0.96	-34,993	809,281	0.40%

Are Funds Buying or Selling LNSR?

Are funds buying LNSR calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own LNSR

No. of Funds

Unveiling LENSAR, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	park west asset management llc	9.9%	1,115,686	SC 13G/A
Feb 13, 2024	curtis nicholas t	7.9%	906,808	SC 13G/A
Feb 09, 2024	dimensional fund advisors lp	5.9%	660,682	SC 13G/A
Dec 11, 2023	madison avenue partners, lp	0.4%	45,743	SC 13G/A
May 19, 2023	north run capital, lp	9.91%	1,100,592	SC 13D
Feb 14, 2023	silver point capital l.p.	4.4%	480,845	SC 13G/A
Feb 14, 2023	madison avenue partners, lp	6.1%	669,046	SC 13G/A
Feb 13, 2023	north run capital, lp	9.95%	1,096,406	SC 13G/A
Feb 10, 2023	dimensional fund advisors lp	6.1%	677,467	SC 13G/A
Feb 08, 2023	curtis nicholas t	7.4%	821,884	SC 13G/A

Recent SEC filings of LENSAR, Inc.

View All Filings

Date Filed	Form Type	Document
May 13, 2024	8-K	Current Report
May 09, 2024	10-Q	Quarterly Report
May 09, 2024	4	Insider Trading
May 09, 2024	4	Insider Trading
May 09, 2024	4	Insider Trading
May 09, 2024	4	Insider Trading
May 09, 2024	4	Insider Trading
May 09, 2024	4	Insider Trading
May 09, 2024	4	Insider Trading
May 09, 2024	8-K	Current Report

Peers (Alternatives to LENSAR, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	181.0B	40.3B	-1.75%	-4.07%	32.18	4.49	-2.84%	-3.08%
BDX	68.3B	19.7B	1.78%	-6.05%	51.24	3.46	4.82%	-17.56%
ALGN	20.4B	3.9B	-9.57%	-7.50%	44.2	5.22	5.72%	46.72%
BAX	18.0B	14.9B	-10.73%	-18.01%	6.79	1.21	2.98%	207.68%
MID-CAP
ATR	9.8B	3.5B	6.68%	24.08%	31.27	2.76	6.16%	35.06%
HSIC	9.6B	12.5B	6.31%	-2.51%	24.63	0.77	-0.61%	-18.83%
BIO	8.4B	2.6B	1.13%	-22.65%	-26.02	3.22	-6.25%	-68.62%
XRAY	5.9B	3.9B	-6.79%	-30.12%	-62.84	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	0.52%	31.17%	-216.3	8.9	30.82%	65.57%
PDCO	2.3B	6.6B	0.19%	-5.50%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	5.94%	-10.00%	-1.91	0.41	7.94%	-1661.78%
ANIK	376.6M	169.3M	-1.13%	-2.23%	-4.9	2.23	7.49%	-244.90%
ANGO	241.9M	324.0M	-4.58%	-37.15%	-1.26	0.75	-3.19%	-337.41%
APYX	56.1M	50.5M	22.73%	-73.49%	-2.46	1.11	14.25%	-10.06%
AEMD	1.0M	3.7M	-71.83%	-87.10%	-0.09	0.28	5.77%	8.23%

LENSAR, Inc. News

Latest updates

LENSAR, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3
Revenue	-12.5%	10,588,000	12,105,000	9,795,000	12,012,000	8,252,000	10,232,000	7,748,000	8,038,000	9,340,000	11,222,000	8,272,000	7,922,000	7,043,000	8,284,000	7,145,000	5,047,000	5,906,000	6,987,000	8,068,000
Cost Of Revenue	-29.2%	4,924,000	6,956,000	4,918,000	5,251,000	3,932,000	3,750,000	3,859,000	3,146,000	4,648,000	5,592,000	4,421,000	3,464,000	3,149,000	3,619,000	3,249,000	3,101,000	2,338,000	-	4,793,000
S&GA Expenses	6.6%	6,796,000	6,374,000	5,117,000	7,854,000	6,755,000	7,204,000	6,119,000	7,569,000	6,278,000	5,811,000	6,523,000	5,518,000	6,035,000	8,658,000	6,290,000	4,041,000	4,779,000	-	3,964,000
R&D Expenses	-1.3%	1,444,000	1,463,000	1,527,000	1,499,000	1,650,000	1,615,000	1,577,000	3,834,000	4,788,000	3,422,000	3,184,000	3,006,000	2,746,000	2,543,000	2,005,000	1,434,000	1,571,000	-	4,331,000
EBITDA Margin	-	-	-	-	-	-	-	-	-0.48	-0.49	-0.52	-	-	-0.67	-0.70	-0.48	-0.45	-0.42	-0.41	-
Interest Expenses	-	13,000	-	-	-	1,000	-	-	-	-	-	-	-	-	-	65,000	671,000	604,000	-	494,000
Income Taxes	-	-	-	-	17,000	1,000	-7,000	-	-	-	-	-	-	-	-	-	-	-	-	-
EBT Margin	-	-	-	-	-	-	-	-	-0.53	-0.53	-0.57	-	-	-0.72	-0.75	-0.55	-0.53	-0.49	-0.48	-
Net Income	45.1%	-2,157,000	-3,926,000	2,568,000	-8,753,000	-4,272,000	-2,490,000	-3,991,000	-6,759,000	-6,674,000	-3,902,000	-6,155,000	-4,362,000	-5,182,000	-6,828,000	-4,763,000	-4,497,000	-3,686,000	-2,468,000	-5,818,000
Net Income Margin	19.2%	-0.28	-0.34	-0.32	-0.51	-0.51	-0.56	-0.59	-0.64	-0.57	-0.57	-0.71	-0.70	-	-	-	-	-	-	-
Free Cashflow	-914.7%	-5,327,000	-525,000	-341,000	-2,325,000	-6,704,000	-4,815,000	-4,703,000	-2,800,000	-2,653,000	-895,000	-2,213,000	-1,482,000	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2019Q4
Assets	-5.0%	66.00	70.00	71.00	71.00	52.00	56.00	55.00	59.00	60.00	66.00	68.00	72.00	74.00	79.00	81.00	35.00
Current Assets	-8.6%	42.00	46.00	49.00	49.00	30.00	34.00	32.00	35.00	39.00	45.00	47.00	52.00	53.00	58.00	60.00	17.00
Cash Equivalents	-32.3%	14.00	21.00	25.00	25.00	8.00	15.00	19.00	25.00	29.00	32.00	32.00	35.00	36.00	41.00	43.00	5.00
Inventory	13.6%	18.00	16.00	17.00	18.00	16.00	12.00	8.00	6.00	4.00	6.00	10.00	12.00	13.00	13.00	14.00	8.00
Net PPE	10.0%	1.00	1.00	0.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Liabilities	-8.3%	21.00	22.00	21.00	25.00	13.00	14.00	12.00	14.00	10.00	12.00	11.00	11.00	9.00	12.00	12.00	65.00
Current Liabilities	-10.2%	10.00	12.00	11.00	11.00	10.00	11.00	10.00	11.00	8.00	9.00	8.00	8.00	6.00	8.00	8.00	8.00
Shareholder's Equity	-4.8%	32.00	33.00	36.00	33.00	39.00	42.00	43.00	45.00	50.00	55.00	57.00	62.00	64.00	67.00	69.00	-
Retained Earnings	-1.9%	-114	-111	-107	-110	-101	-97.51	-95.02	-91.03	-84.27	-77.59	-73.69	-67.54	-63.17	-57.99	-51.16	-38.18
Additional Paid-In Capital	0.4%	146	145	144	143	141	139	137	136	134	132	131	129	127	125	120	8.00
Shares Outstanding	0.6%	11.00	11.00	11.00	11.00	11.00	11.00	10.00	10.00	10.00	11.00	9.00	9.00	-	-	-	-
Float	-	-	-	-	34.00	-	-	-	59.00	-	-	-	79.00	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																			(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3
Cashflow From Operations	-1005.6%	-5,307	-480	-339	-2,144	-6,696	-4,758	-4,701	-2,790	-2,607	-739	-2,149	-1,462	-4,619	-1,997	-55.00	-5,375	-6,364	-	-
Share Based Compensation	-20.1%	652	816	1,173	1,824	1,726	1,695	1,672	1,637	1,607	1,543	1,573	1,430	2,320	5,135	3,872	-	38.00	-	-
Cashflow From Investing	69.1%	-1,226	-3,965	-2.00	-181	-8.00	-57.00	-2.00	-10.00	-46.00	-156	-64.00	-20.00	-114	-105	14.00	-142	-93.00	-	-
Cashflow From Financing	-189.0%	-130	146	-205	-	-	196	-1,200	-	-	191	-	-	-	-	37,927	7,690	4,384	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

LNSR Income Statement

2024-03-31

CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue
Product and service revenue	$ 8,641	$ 6,623
Lease	1,947	1,629
Total revenue	10,588	8,252
Cost of revenue (exclusive of amortization)
Total cost of revenue	4,924	3,932
Operating expenses
Selling, general and administrative expenses	6,796	6,755
Research and development expenses	1,444	1,650
Amortization of intangible assets	274	276
Operating loss	(2,850)	(4,361)
Other income
Change in fair value of warrant liabilities	495
Other income, net	198	89
Net loss	(2,157)	(4,272)
Other comprehensive loss
Change in unrealized loss on investments	(5)
Net loss and comprehensive loss	$ (2,162)	$ (4,272)
Net loss per common share:
Basic	$ (0.19)	$ (0.4)
Diluted	$ (0.19)	$ (0.4)
Weighted-average number of common shares used in calculation of net loss per share:
Basic	11,387	10,716
Diluted	11,387	10,716
Product
Revenue
Product and service revenue	$ 7,433	$ 5,658
Cost of revenue (exclusive of amortization)
Total cost of revenue	2,590	2,299
Service
Revenue
Product and service revenue	1,208	965
Cost of revenue (exclusive of amortization)
Total cost of revenue	1,731	1,139
Lease
Revenue
Lease	1,947	1,629
Cost of revenue (exclusive of amortization)
Total cost of revenue	$ 603	$ 494

LNSR Balance Sheet

2024-03-31

CONDENSED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 13,958	$ 20,621
Short-term investments	3,952	3,443
Accounts receivable, net of allowance of $44 and $62, respectively	4,023	4,001
Notes receivable, net of allowance of $7 and $7, respectively	329	323
Inventories	17,816	15,689
Prepaid and other current assets	2,357	2,367
Total current assets	42,435	46,444
Property and equipment, net	747	679
Equipment under lease, net	7,727	7,459
Long-term investments	1,236	492
Notes and other receivables, long-term, net of allowance of $24 and $26, respectively	1,174	1,279
Intangible assets, net	10,751	11,025
Other assets	2,064	2,207
Total assets	66,134	69,585
Current liabilities:
Accounts payable	4,120	4,007
Accrued liabilities	4,180	5,717
Deferred revenue	1,582	1,349
Operating lease liabilities	564	559
Total current liabilities	10,446	11,632
Long-term operating lease liabilities	1,607	1,750
Warrant liabilities	7,962	8,457
Other long-term liabilities	537	570
Total liabilities	20,552	22,409
Commitments and contingencies (Note 10)
Series A Redeemable Convertible Preferred Stock, par value $0.01 per share, 20 shares authorized at March 31, 2024 and December 31, 2023; 20 shares issued and outstanding at March 31, 2024 and December 31, 2023; aggregate liquidation preference of $20,000 at March 31, 2024 and December 31, 2023	13,747	13,747
Stockholders’ equity:
Preferred stock, par value $0.01 per share, 9,980 shares authorized at March 31, 2024 and December 31, 2023; no shares issued and outstanding at March 31, 2024 and December 31, 2023
Common stock, par value $0.01 per share, 150,000 shares authorized at March 31, 2024 and December 31, 2023; 11,395 and 11,327 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	114	113
Additional paid-in capital	145,770	145,203
Accumulated other comprehensive income	(1)	4
Accumulated deficit	(114,048)	(111,891)
Total stockholders’ equity	31,835	33,429
Total liabilities, redeemable convertible preferred stock, and stockholders' equity	$ 66,134	$ 69,585

About LENSAR, Inc.

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

CEO	Mr. Nicholas T. Curtis
WEBSITE	lensar.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	110

LENSAR, Inc. Frequently Asked Questions

What is the ticker symbol for LENSAR, Inc.? What does LNSR stand for in stocks?

LNSR is the stock ticker symbol of LENSAR, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of LENSAR, Inc. (LNSR)?

As of Fri May 17 2024, market cap of LENSAR, Inc. is 46.96 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of LNSR stock?

You can check LNSR's fair value in chart for subscribers.

What is the fair value of LNSR stock?

You can check LNSR's fair value in chart for subscribers. The fair value of LENSAR, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of LENSAR, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for LNSR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is LENSAR, Inc. a good stock to buy?

The fair value guage provides a quick view whether LNSR is over valued or under valued. Whether LENSAR, Inc. is cheap or expensive depends on the assumptions which impact LENSAR, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LNSR.

What is LENSAR, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, LNSR's PE ratio (Price to Earnings) is -3.83 and Price to Sales (PS) ratio is 1.06. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LNSR PE ratio will change depending on the future growth rate expectations of investors.